Cabozantinib induces intracranial / extracranial responses in metastatic RCC | Targeted oncology
In patients with metastatic renal cell carcinoma (RCC) with brain metastases, treatment with cabozantinib (Cabometyx) showed intracranial and extracranial masses, results from a retrospective study…
